In order to bridge this knowledge gap, we conducted a comparative study of the treatment outcomes of proton IRT and photon IRT using a mouse model of anti-PD1 (αPD1)-resistant lung cancer [16]. The gene discussed is PDCD1; the disease is lung cancer.